Genome BC Funds $9.8M Project to Identify Subgroups in Medulloblastoma for Personalized Treatment
February 15, 2012
Genome BC Funds $9.8M Project to Identify Subgroups in Medulloblastoma for Personalized Treatment
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Dual Study First to Suggest Genetic Basis for Personalized Adjunctive Tuberculosis Treatment
February 22, 2012 / Pharmacogenomics Reporter - Genome BC Funds $9.8M Project to Sequence 1K Childhood Brain Tumors
February 1, 2012 / Clinical Sequencing News - GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter - TCGA Study Shows Molecular Subtypes May Better Stratify Endometrial Cancer Patients than Histology
May 1, 2013 / Pharmacogenomics Reporter - New Weill Cornell Precision Medicine Institute Plans to Offer Genomically Guided Treatment after CLIA Approval
February 6, 2013 / Pharmacogenomics Reporter